A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation
Venous thromboembolism (VTE) is a life-threatening complication, especially in case of recurrence. The appropriate duration of anticoagulant treatment following the first event is crucial. Risk factors that increase the risk of recurrence of VTE are many, and include medications, kidney disease, ren...
Main Authors: | Rosario Di Maggio, Alessandra Giuliano, Disma Renda, Giuseppina Calvaruso, Simona Raso, Lorella Pitrolo, Antonio Carroccio, Aurelio Maggio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Thalassemia Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2039-4365/12/3/13 |
Similar Items
-
Relationship between the type of atrial fibrillation and thromboembolic events
by: Potpara Tatjana, et al.
Published: (2009-01-01) -
Role of iron metabolism genetic determinants in response to chelation therapy in a cohort of β-thalassemia and sickle cell syndromes Italian patients
by: Maria Concetta Renda, et al.
Published: (2014-09-01) -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
by: Zohreh Rahimi, et al.
Published: (2011-01-01) -
Risk factors for Venous Thromboembolism and clinical outcomes in adults with sickle cell disease
by: Brittany Scarpato, et al.
Published: (2022-03-01) -
Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis
by: Jean Jacques Noubiap, et al.
Published: (2018-10-01)